DLA Piper advises Ellimist Singapore on series of significant pharmaceutical M&A transactions | DLA Piper

[ad_1] DLA Piper has advised Ellimist Singapore on its successful acquisition of Sagent Pharmaceuticals and Omega Laboratories from Nichi-Iko Pharmaceutical, the Tokyo Stock Exchange listed Japanese company. Sagent Pharmaceuticals is…